ACEBROPHYLLINE

Acebrophylline, a xanthine derivative, is prescribed as a bronchodilator for the treatment of bronchial asthma and copd in adults. Acebrophylline alter mucus gel secretion phase by lowering viscosity and increasing the serous gel phase. By augmenting ciliary motility, acebrophylline increases the mucociliary clearance.